Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1992
Cyclosporine and FK506 inhibition of murine mast cell cytokine production
S M Hatfield, N W Roehm
The Journal of Experimental Medicine
|
July 1, 1982
Antigen-specific, H-2-restricted helper T cell hybridomas
N W Roehm, P Marrack, J W Kappler
The Journal of Experimental Medicine
|
August 1, 1983
Helper signals in the plaque-forming cell response to protein-bound haptens
N W Roehm, P Marrack, J W Kappler
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1992
Rapamycin and FK506 differentially inhibit mast cell cytokine production and cytokine-induced proliferation and act as reciprocal antagonists
S M Hatfield, J S Mynderse, N W Roehm
Immunological Investigations
|
February 1, 1991
Patterns of lymphokine production by primary antigen-specific/MHC restricted murine helper T cell clones
S M Hatfield, G H Rodgers, P Marder, et al.
Journal of Immunological Methods
|
September 13, 1991
An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT
N W Roehm, G H Rodgers, S M Hatfield, et al.
The Biochemical Journal
|
December 15, 1994
Phosphorylation and activation of Ca(2+)-sensitive cytosolic phospholipase A2 in MCII mast cells mediated by high-affinity Fc receptor for IgE
S Currie, E F Roberts, S M Spaethe, et al.
The Journal of Experimental Medicine
|
September 1, 1984
Interleukin-induced increase in Ia expression by normal mouse B cells
N W Roehm, H J Leibson, A Zlotnik, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 1985
The major histocompatibility complex-restricted antigen receptor on T cells: the genetics of expression of an allotype
N W Roehm, A Carbone, E Kushnir, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 23, 1999
Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI
D W Snyder, N J Bach, R D Dillard, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1992
Cyclosporine and FK506 inhibition of murine mast cell cytokine production
S M Hatfield, N W Roehm
The Journal of Experimental Medicine
|
July 1, 1982
Antigen-specific, H-2-restricted helper T cell hybridomas
N W Roehm, P Marrack, J W Kappler
The Journal of Experimental Medicine
|
August 1, 1983
Helper signals in the plaque-forming cell response to protein-bound haptens
N W Roehm, P Marrack, J W Kappler
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1992
Rapamycin and FK506 differentially inhibit mast cell cytokine production and cytokine-induced proliferation and act as reciprocal antagonists
S M Hatfield, J S Mynderse, N W Roehm
Immunological Investigations
|
February 1, 1991
Patterns of lymphokine production by primary antigen-specific/MHC restricted murine helper T cell clones
S M Hatfield, G H Rodgers, P Marder, et al.
Journal of Immunological Methods
|
September 13, 1991
An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT
N W Roehm, G H Rodgers, S M Hatfield, et al.
The Biochemical Journal
|
December 15, 1994
Phosphorylation and activation of Ca(2+)-sensitive cytosolic phospholipase A2 in MCII mast cells mediated by high-affinity Fc receptor for IgE
S Currie, E F Roberts, S M Spaethe, et al.
The Journal of Experimental Medicine
|
September 1, 1984
Interleukin-induced increase in Ia expression by normal mouse B cells
N W Roehm, H J Leibson, A Zlotnik, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 1985
The major histocompatibility complex-restricted antigen receptor on T cells: the genetics of expression of an allotype
N W Roehm, A Carbone, E Kushnir, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 23, 1999
Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI
D W Snyder, N J Bach, R D Dillard, et al.
Page
of 1